Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

Published: December 25, 2025 D-Wave Quantum Inc. (NYSE: QBTS) heads into the Christmas break with the kind of chart that makes both momentum traders and risk managers reach for caffeine: a big 2025 run, a sharp December surge tied to fresh visibility at CES 2026, and then a quick pullback as the market digests insider-selling headlines and a valuation that’s sprinted far ahead of current revenue. Because U.S. markets are closed on December 25, the most recent regular-session print investors have is Wednesday, Dec. 24, when QBTS closed at $27.52, down about 5.5% on the day, after trading between roughly
25 December 2025
··
Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings Inc. (NASDAQ: ONDS) heads into the Christmas holiday with investors focused less on day-to-day trading (U.S. markets are closed on December 25) and more on a late‑2025 sequence of contracts, acquisitions, and defense-focused expansion moves that have reshaped the company’s narrative. In the shortened Christmas Eve session (Dec. 24, 2025), ONDS last traded around $9.07. StockAnalysis That price level matters for one simple reason: after a year of dramatic swings, Ondas is now being valued like a company the market expects to become a meaningful player in counter-drone (C‑UAS), autonomous surveillance, and multi-domain robotics—but it still has to
25 December 2025
···
American Airlines Stock (NASDAQ: AAL) Today: Latest News, Analyst Forecasts, and What to Watch for 2026 (Dec. 25, 2025)

American Airlines Stock (NASDAQ: AAL) Today: Latest News, Analyst Forecasts, and What to Watch for 2026 (Dec. 25, 2025)

December 25, 2025 — U.S. markets are closed for Christmas Day, so American Airlines Group Inc. (NASDAQ: AAL) is effectively “on pause” after Wednesday’s shortened Christmas Eve session. The Economic Times As of the last trade on Dec. 24, 2025, AAL finished around $15.68, up modestly on the day, after trading between roughly $15.49 and $15.74 in that early-close session. That headline number looks calm. The story underneath it is not. Over the past two weeks, AAL has been tugged by three forces that matter a lot for airline stocks heading into 2026: Below is a full, up-to-date roundup of
25 December 2025
AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Triggers Wild Swing as 2026 Direct-to-Cell Ambitions Come Into Focus

AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Triggers Wild Swing as 2026 Direct-to-Cell Ambitions Come Into Focus

Dec. 25, 2025 — AST SpaceMobile, Inc. (NASDAQ: ASTS) is ending 2025 the way speculative “future-of-connectivity” stocks tend to end years: with a headline-grabbing technical milestone, a massive burst of trading activity, and a share price that refuses to move in a straight line. The catalyst is BlueBird 6—AST SpaceMobile’s first next‑generation satellite aimed at delivering 4G/5G cellular broadband directly to standard, unmodified smartphones. The company confirmed the satellite reached orbit after launching from India late on Dec. 23 (U.S. time), and the stock’s reaction on Christmas Eve was dramatic: ASTS spiked early, then reversed hard into the close, underscoring
25 December 2025
UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

December 25, 2025 — UiPath Inc. (NYSE: PATH) is closing out 2025 in the spotlight after a powerful, index-driven rally that pushed the automation software maker back onto investors’ year-end watchlists. With U.S. markets shut for Christmas Day, the conversation is now shifting from “why it moved” to “what the move changes”—for liquidity, ownership, and expectations heading into 2026. Reuters As of the most recent trade (the shortened Christmas Eve session), UiPath shares were around $17.16, after trading between roughly $16.70 and $17.36. What’s new on Dec. 25, 2025 isn’t a surprise product launch or an earnings shock. It’s a
25 December 2025
··
BigBear.ai (BBAI) Stock: Latest News, Analyst Forecasts, and 2026 Outlook as of Dec. 25, 2025

BigBear.ai (BBAI) Stock: Latest News, Analyst Forecasts, and 2026 Outlook as of Dec. 25, 2025

BigBear.ai Holdings, Inc. (NYSE: BBAI) is heading into the final week of 2025 with a familiar mix of ingredients that tends to supercharge small-cap AI stocks: a big strategic acquisition, fresh defense-adjacent partnerships, and a shareholder vote that could materially change the company’s capital flexibility. As of Dec. 25, 2025, the most recent official market data shows BBAI last traded at $6.03, down $0.09 (-1.47%) on the latest session data available, with a market cap around $2.64 billion. What follows is a detailed, publication-ready roundup of the most current news and analysis circulating on and around Dec. 25, 2025, plus
25 December 2025
Tesla Stock News Today (Dec. 25, 2025): TSLA Faces Fresh NHTSA Probe, Q4 Delivery Countdown, and Split Wall Street Forecasts

Tesla Stock News Today (Dec. 25, 2025): TSLA Faces Fresh NHTSA Probe, Q4 Delivery Countdown, and Split Wall Street Forecasts

Tesla, Inc. (NASDAQ: TSLA) stock is entering the Christmas break with a familiar mix of momentum and controversy: a sky-high valuation story tied to autonomy, robotics, and energy storage—colliding with another round of safety scrutiny and ongoing questions about vehicle demand. Because U.S. markets are closed on Thursday, December 25, 2025, there’s no new trading action in TSLA today. The latest price discovery comes from Wednesday’s holiday-shortened session (Dec. 24)—and it arrived just as regulators opened a new investigation into Tesla’s emergency door release design. New York Stock Exchange Below is a full, publication-ready roundup of the most current Tesla
25 December 2025
··
Plug Power Stock (NASDAQ: PLUG) News on Dec. 25, 2025: Latest Catalysts, Analyst Forecasts, and What Investors Are Watching

Plug Power Stock (NASDAQ: PLUG) News on Dec. 25, 2025: Latest Catalysts, Analyst Forecasts, and What Investors Are Watching

December 25, 2025 — U.S. markets are closed for Christmas Day, so the most recent trading for Plug Power Inc. (NASDAQ: PLUG) is from Wednesday, Dec. 24. Plug Power stock last traded around $2.10, up roughly 2.4% on the day, after a choppy stretch that has kept the shares pinned in the low-$2 range. MarketWatch That one-day bounce, though, doesn’t change the bigger picture: Plug’s stock remains deeply volatile and far below its 52-week high of $4.58 (set Oct. 6), reflecting an investor base still split between “turnaround finally working” and “more dilution and delays ahead.” MarketWatch Below is a
25 December 2025
··
NVIDIA Stock News (Dec. 25, 2025): NVDA’s Groq Inference Deal, China H200 Export Twist, and CES 2026 Catalyst

NVIDIA Stock News (Dec. 25, 2025): NVDA’s Groq Inference Deal, China H200 Export Twist, and CES 2026 Catalyst

December 25, 2025 — U.S. markets are closed for Christmas Day, but NVIDIA Corporation (NASDAQ: NVDA) investors have plenty to digest after a headline-heavy week for the AI-chip leader. NVDA last traded around $188.61 in the most recent session available (Christmas Eve trading), as investors weighed fresh deal news, shifting U.S.–China chip policy signals, and a coming spotlight at CES 2026. Investors What follows is a full roundup of the current NVIDIA stock news, analyst forecasts, and market analysis as of 25.12.2025—and what they may signal for NVDA into early 2026. The biggest NVIDIA stock headline: Groq licensing deal (not
25 December 2025
·
FDA Frozen Shrimp Recall Over Cesium-137: Market 32 and Waterfront Bistro Products Pulled Across 17 States

FDA Frozen Shrimp Recall Over Cesium-137: Market 32 and Waterfront Bistro Products Pulled Across 17 States

Dec. 25, 2025 — If shrimp cocktail, shrimp scampi, or a quick freezer-to-pan seafood dinner is part of your holiday week, check your freezer before you cook. A new FDA-posted recall involves about 83,800 bags of frozen raw shrimp that may have been exposed to cesium-137 (Cs‑137), a man-made radioactive isotope. The recalled shrimp was imported from Indonesia and distributed in the U.S. under Market 32 and Waterfront Bistro labels by Direct Source Seafood LLC of Bellevue, Washington, according to federal and company recall notices. U.S. Food and Drug Administration The FDA and the company stress that this recall is
25 December 2025
Giant Holiday Hours 2025: Which Giant Stores Are Open on Christmas Day—and Which Are Closed

Giant Holiday Hours 2025: Which Giant Stores Are Open on Christmas Day—and Which Are Closed

December 25, 2025 — If you woke up on Christmas morning missing a key ingredient for dinner (or suddenly remembered you promised to bring “just one more thing”), you’re not alone. Across the U.S., most major retailers and grocery chains are dark today, but “Giant” shoppers are seeing something different: some Giant-branded supermarkets are open with limited hours, while others are fully closed—and the difference often comes down to which “Giant” you mean. Red94 That confusion is one reason “Is Giant open on Christmas Day 2025?” has surged as a holiday search query. Today’s reporting and store listings show a
25 December 2025
·
BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

BP sells 65% of Castrol to Stonepeak in $10.1bn deal as Castrol India open offer follows

LONDON / NEW YORK — December 25, 2025 — BP has agreed to sell a 65% stake in Castrol to Stonepeak in a transaction valuing the lubricants business at about $10.1 billion, marking one of the oil major’s biggest moves yet in its multi‑year effort to simplify operations, cut debt, and sharpen its strategic focus. London South East While the headline announcement landed on December 24, the story continued to develop on December 25 as attention shifted to what the deal means for BP’s balance sheet, Stonepeak’s bet on a cash‑generative industrial brand, and a required open offer for Castrol
25 December 2025
····
Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum

Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum

December 25, 2025 — Merck & Co., Inc. (NYSE: MRK) is ending 2025 with something investors tend to enjoy: momentum with a story behind it. Even with U.S. markets closed for Christmas Day, Merck shares are in focus after a late-December climb that pushed the stock to fresh highs, helped along by a major Wall Street upgrade and a burst of pipeline and regulatory headlines. MarketBeat Below is what’s moving Merck stock, what the latest MRK forecasts imply for 2026, and the near-term catalysts (and risks) that could decide whether this rally is the start of a new chapter—or just
25 December 2025
··
Tim Cook Buys $3 Million in Nike Stock as S&P 500 Hits Record Highs; Gold Hovers Near $4,500 in Holiday “Santa Rally” Trade

Tim Cook Buys $3 Million in Nike Stock as S&P 500 Hits Record Highs; Gold Hovers Near $4,500 in Holiday “Santa Rally” Trade

Dec. 25, 2025 — With U.S. markets closed for Christmas Day, investors are spending the holiday digesting a rare combination of headline signals: a high-profile insider buy at Nike by Apple CEO Tim Cook, record closes for the S&P 500 and Dow Jones Industrial Average, and a commodities complex that has turned “year-end” into “record-end,” led by gold’s surge to the doorstep of $4,500 an ounce. CNA The backdrop is classic late-December: light trading volumes, seasonal optimism, and traders watching whether the market can extend the so-called Santa Claus rally window into the final sessions of the year and the
25 December 2025
···
Rhode Island Christmas Day 2025 Grocery Store Hours: What’s Open, What’s Closed, and Why

Rhode Island Christmas Day 2025 Grocery Store Hours: What’s Open, What’s Closed, and Why

PROVIDENCE, R.I. — Thursday, Dec. 25, 2025 (Christmas Day) has a familiar surprise for last-minute shoppers across Rhode Island: the big grocery run you’re hoping to make simply isn’t happening. Whether it’s the forgotten carton of milk, a missing stick of butter, or an “emergency” bag of ice, Christmas Day in Rhode Island is one of the toughest days of the year to shop—because most full-size grocery stores and major retailers are shut down, and the few places that are open often keep shortened hours. Here’s what Rhode Islanders need to know today about Christmas Day 2025 grocery store hours,
25 December 2025
Johnson & Johnson Stock (JNJ) Update: Price, Latest News, Analyst Forecasts and Key Risks on December 25, 2025

Johnson & Johnson Stock (JNJ) Update: Price, Latest News, Analyst Forecasts and Key Risks on December 25, 2025

December 25, 2025 — Johnson & Johnson stock (NYSE: JNJ) is in “holiday mode” today, with U.S. markets closed for Christmas Day after an early close on Christmas Eve. Investopedia The last regular-session print before the holiday was $207.78 (Dec. 24 close), keeping JNJ near the upper end of its 2025 range. Nasdaq+1 That calm surface hides a busy catalyst stack that investors are carrying into the final trading days of 2025 and the first earnings checkpoint of 2026: fresh talc verdict headlines, new FDA-related momentum, Washington drug-pricing politics, and a steady drumbeat of analyst price-target revisions. JNJ stock price
25 December 2025
·
Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

The Walt Disney Company (NYSE: DIS) heads into the Christmas holiday with its stock perched near the mid-$110s after a strong month—and with Wall Street’s attention split between Disney’s own execution (streaming profitability, parks cash flow, and capital returns) and the industry’s rapidly shifting chessboard (most notably, the Warner Bros. Discovery bidding battle). Nasdaq Disney shares last closed at $114.48 (Dec. 24), capping a roughly 9.6% gain over the past month, according to a widely circulated Zacks/Nasdaq market wrap. Nasdaq Below is a comprehensive roundup of the most current Disney stock news, forecasts, and analyst takes circulating as of 25.12.2025,
25 December 2025
···
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb Company (NYSE: BMY) heads into Dec. 25, 2025 with its stock anchored in the mid-$50s — and with investors juggling two competing storylines: With U.S. markets effectively pausing for the holiday, the most recent available NYSE quote showed BMY around $54.71 (last trade timestamp recorded Dec. 24), after trading between roughly $54.20 and $54.75 intraday. Bristol Myers Squibb Investors Bristol-Myers Squibb stock price today: where BMY stands into Dec. 25, 2025 BMS’s own investor quote page showed BMY at $54.71 on Dec. 24 (delayed quote), with a prior close listed as $54.28 and a 52-week range of $42.52
25 December 2025
···
Lucid Stock (LCID) Today: Latest News, Analyst Forecasts, and What’s Driving Lucid Group Shares on Dec. 25, 2025

Lucid Stock (LCID) Today: Latest News, Analyst Forecasts, and What’s Driving Lucid Group Shares on Dec. 25, 2025

Lucid Group, Inc. (NASDAQ: LCID) heads into Christmas Day with its stock still pinned near the lows that have defined much of 2025. With U.S. markets closed for the holiday, the most recent trade was $11.81 (Dec. 24), after an intraday range of $11.62–$11.845. For investors watching Lucid stock right now, the story is a three-way tug-of-war: Below is a detailed, news-forward roundup of what’s happening around Lucid stock as of Dec. 25, 2025, and what the latest forecasts and analyses are emphasizing. Lucid stock price check on Dec. 25, 2025: where LCID stands Because Christmas Day is a market
25 December 2025
··
Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research Corporation (NASDAQ: LRCX) heads into Christmas Day with momentum—and a few headline-worthy crosscurrents. In the last U.S. trading session before the holiday (a shortened Christmas Eve session), LRCX closed at $177.33, marking a fresh 52‑week high as the broader market also finished at record levels. MarketWatch But the story investors are chewing on isn’t just “new high.” It’s new high + insider sale + a wave of analyst target changes + a sector narrative built around AI-driven memory demand—with real policy risk sitting in the background like a plot twist you can’t skip. Below is a full, publication-ready
25 December 2025
·
1 … 324 325 326 327 328 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop